Trial Profile
A Study of Bimatoprost 0.01% in the Clinical Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms APPEAL-Taiwan
- Sponsors Allergan
- 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 New trial record